Savant HWP, Inc.
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Savant HWP, Inc.
Best Of BIO: Policy & Regulatory Updates From BIO 2017
Antibiotic incentives, vaccine strategies, drug pricing, patent updates and more hot topics from the Biotechnology Innovation Organization's recent annual conference.
Start-Up Previews, February 2013
This Month's Profile Group: Medtech Start-Ups Battle Advanced Skin Cancer With Innovative Technologies, features profiles of OncoSec, Sensus Healthcare, and Siva Therapeutics. Plus these Start-Ups Across Health Care: Avillion, CardioLogical Solutions, Fixes 4 Kids, RenovoRx, and Savant HWP.
Savant HWP Inc.
The founders of Savant HWP Inc. believe they have identified a molecule that could prove effective in treating many kinds of substance as well as behavioral addictions, because it appears to influence relevant brain chemistry at a fundamental level. Its compound binds to the alpha-3-beta-4 nicotinic acetylcholine receptor and appears to indirectly regulate production of dopamine in the mid-brain.
Company Information
- Industry
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Savant Neglected Diseases, LLC
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice